Scilex Holding Company Preferred Stock, Value, Issued
Scilex Holding Company (SCLX) had Preferred Stock, Value, Issued of $0 as of 2024-09-30, per its 10-Q filed 2025-01-17.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2025-01-17
- 2024-09-30: Preferred Stock, Value, Issued $0.00.
- 2024-06-30: Preferred Stock, Value, Issued $0.00.
- 2024-03-31: Preferred Stock, Value, Issued $0.00.
- 2023-12-31: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2025-01-17 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 |
| 2023-12-31 | $0.00 10-Q · filed 2025-01-17 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $3.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $3.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $3.00K 10-K · filed 2024-03-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |